In an important step towards the early diagnosis of heart diseases, researchers have succeeded in developing a simple home test. This test, which is designed based on electrochemical biotechnology, can detect the presence of biomarkers related to heart failure using a drop of saliva and in a very short period of time (about 15 minutes).
This test works by measuring the level of a protein called BNP (type B natriuretic peptide) in saliva. An increase in the level of this protein in the blood indicates the pressure on the heart. By using this test, people at risk can easily monitor their heart condition at home and see a doctor if necessary.
The advantages of the home test for diagnosing heart failure are its simplicity and speed. Performing this test is very simple and its results are available in a short time. By using this test, people in remote and underserved areas can easily access diagnostic services. Also, with early and continuous diagnosis of the disease, it is possible to prevent the progress of the disease and the need for more complex treatments.
Despite the promising results, this test is still in the early stages of development and requires more extensive clinical studies. Researchers are trying to increase the accuracy and sensitivity of this test and prepare it for commercial use. The development of the home test for the diagnosis of heart failure is considered a great development in the field of diagnosis and treatment of heart diseases. This achievement can help improve the quality of life of patients and reduce treatment costs.
RCO NEWS